期刊文献+

肝细胞癌中转录因子E2F7对Wnt/β-catenin信号通路活性的影响 被引量:2

The Effect of Transcription Factor E2F7 on Wnt/β-catenin Signaling Pathway in Hepatocellular Carcinoma
下载PDF
导出
摘要 探讨肝细胞癌(HCC)中非典型性E2F家族成员E2F7在肝癌细胞生长、分化中的作用及可能涉及的分子机制.本研究运用实时荧光定量PCR检测38例原发性肝细胞癌及对应的癌旁组织中E2F7基因mRNA的表达情况;分别通过基因过表达和RNA干扰技术上调或下调E2F7基因表达,并运用实时荧光定量PCR和Western印迹检测肝癌细胞株MHCC-H中β-catenin及其靶基因cmyc的表达情况;双荧光素酶报告基因系统检测E2F7对Wnt/β-catenin信号通路活性的影响;核浆分离实验检测过表达E2F7基因对β-catenin入核的影响;免疫共沉淀实验检测异位表达E2F7与内源β-catenin的相互作用.结果显示,肝细胞癌组织中E2F7基因的表达量显著高于相应的癌旁组织(P<0.001);转录因子E2F7可与β-catenin相互作用并促进β-catenin进入细胞核.转录因子E2F7可以促进Wnt/β-catenin信号通路的活性. To explore role of transcription factor E2F7 on Wnt/β-catenin signaling pathway in hepatocellular carcinoma (HCC) cells, the expression of E2F7 mRNA was analyzed using realtime PCR in 38 pairs of primary HCC and corresponding adjacent tissues. In MHCCH cells, over expression and RNA interference technology were applied to up-regulate or downregulate the E2F7 gene expression. Changes of β-catenin and downstream c-myc gene expression were detected by real-time PCR and immunoblot assays. Furthermore, dual-luciferase reporter assay was used to evaluate the effect of E2F7 on Wnt/β-catenin signal pathway. Nuclear and cytoplasmic separation of β-catenin was performed to measured the over expression effect of E2F7 on its activation in the nucleus.T he interaction between exogenous E2F7 and endogenous β-catenin was verified by coimmunoprecipitation. The results suggested that the mRNA expression level of E2F7 in HCC tissues was significantly higher than adjacent tissues (P 〈0.001). E2F7 interacted with βcatenin increased the translocation of β-catenin into the nucleus, thus to increase the activity of Wnt/β-catenin signaling pathway.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2014年第6期565-570,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金项目(No.81101875) 上海市科委自然科学基金资助项目(No.11ZR1425300)~~
关键词 转录因子E2F7 肝细胞癌 WNT Β-CATENIN信号通路 transcription factor E2F7 hepatocellular carcinoma Wnt/β-catenin signaling pathway
  • 相关文献

参考文献21

  • 1Kawada N,Imanaka K,Kawaguchi T,et al.Hepatocellularcarcinoma arising from non-cirrhotic nonalcoholic steatohepatitis[J].J Gastroenterol,2009,44(12):1190-1194.
  • 2Palaiologou M,Koskinas J,Karanikolas M,et al.E2f-1isoverexpressed and pro-apoptotic in human hepatocellularcarcinoma[J].Virchows Arch,2012,460(5):439-446.
  • 3Liu L X,Jiang H C,Liu Z et al.Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma andadjacent normal liver tissues[J].Oncol Rep,2003,10(6):1771-1775.
  • 4Deng Q,Wang Q,Zong W Y,et al.E2f8 contributes to humanhepatocellular carcinoma via regulating cell proliferation[J].Cancer Res,2010,70(2):782-791.
  • 5Clevers H.Wnt/beta-catenin signaling in development anddisease[J].Cell,2006,127(3〉:469-480.
  • 6Polakis P.The many ways of wnt in cancer[J].Curr OpinGenet Dev,2007,17(1):45-51.
  • 7Klaus A,Birchmeier W.Wnt signalling and its impact ondevelopment and cancer[J].Nat Rev Cancer,2008,8(5):387-398.
  • 8Moon R T,Kohn A D,De Ferrari G V,et al.Wnt and beta-catenin signalling:diseases and therapies[J].Nat Rev Genet,2004,5(9):691-701.
  • 9Wu Z,Zheng S,Li Z,et al.E2F1 suppresses Wnt/beta-cateninactivity through transactivation of beta-catenin interacting proteinICAT[J].Oncogene,2011,30(37):3979-3984.
  • 10Logan N,Graham A,Zhao X,et al.E2F8:an E2F familymember with a similar organization of DNA-binding domain toE2F-7[J].Oncogene,2005,24(31):5000-5004.

同被引文献9

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部